Author(s):
Dima Ahmed, Rana Makhous
Email(s):
DimaIssaAhmed94@gmail.com , rana.makhous@tishreen.edu.sy
DOI:
10.5958/0974-360X.2020.00673.3 
Address:
Dima Ahmed1, Dr. Rana Makhous2
1Master Student in Pharmacology Department, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
2Professor in Pharmacology Department, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
In the last few years, a great interest has aroused in the effects of metformin on thyroid function in diabetic patients. This study aims to evaluate the effect of metformin on serum thyrotropin (TSH) levels in euthyroid type 2 diabetic patients. The study included forty euthyroid diabetic patients, aged between (20–70) years, randomly selected from the outpatient section of endocrinology departments who started metformin treatment at recruitment. Serum TSH levels were measured before and after 6-months of metformin treatment using immune chemiluminescent assay. After 6 months of metformin treatment, mean TSH levels were insignificantly lower than basal TSH levels (p value > 0.05). We divided the study group according to basal TSH levels into two groups, and we found that TSH levels after six months of treatment were significantly higher than basal levels in group 1 (basal TSH < 1.8µIU/ml) but in group 2 (basal TSH > 1.8µIU/ml), TSH levels after six months of treatment were significantly lower than basal levels. In conclusion, our data strengthen the previous observation that metformin treatment does not produce a significant change in TSH levels in euthyroid patients. We also found that metformin may have a buffer effect on TSH levels as its effect differs according to basal levels. This effect may cause some complications in the diagnosis of thyroid dysfunction especially if clinicians rely only on TSH measurement in diagnosis. In conclusion, we should take into account this effect of metformin when we study thyroid function.
Cite this article:
Dima Ahmed, Rana Makhous. Evaluation of the effect of Metformin therapy on TSH serum levels in Diabetic patients. Research J. Pharm. and Tech. 2020; 13(8):3801-3806. doi: 10.5958/0974-360X.2020.00673.3
Cite(Electronic):
Dima Ahmed, Rana Makhous. Evaluation of the effect of Metformin therapy on TSH serum levels in Diabetic patients. Research J. Pharm. and Tech. 2020; 13(8):3801-3806. doi: 10.5958/0974-360X.2020.00673.3 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-8-46
REFERENCES:
1. Haidari, F., et al., The Relationship between Metabolic Factors and Quality of Life Aspects in Type 2 Diabetes Patients. Research Journal of Pharmacy and Technology, 2017. 10(5): p. 1491.
2. Goyal, S., et al., Vascular Endothelial Dysfunction: Complication of Diabetes Mellitus and Hyperhomocysteinemia. Research Journal of Pharmacy and Technology, 2010. 3(3): p. 657-664.
3. Viollet, B., et al., Cellular and molecular mechanisms of metformin: an overview. Clinical Science, 2012. 122(6): p. 253-270.
4. Kumari, M.S., et al., Diabetes Mellitus: Present status and Drug therapy Updates. Research Journal of Pharmacy and Technology, 2014. 7(1): p. 9.
5. Suraj, B., et al., A comparative evaluation of safety, efficacy and cost effectiveness of three add on treatment regimens in type 2 diabetics; not controlled by metformin alone. Research Journal of Pharmacy and Technology, 2015. 8(1): p. 44.
6. Nwauche, K.T., C. Monago, and F. Anacletus, Management of Diabetic induced Hyperlipidemia with Combined Therapy of Reducdyn and Metformin in Streptozotocin induced Diabetic Male Rats. Research Journal of Pharmacy and Technology, 2014. 7(9): p. 11.
7. Maheshwari, P. and T. Shanmugarajan, Evaluation of Prescribing Practices of Metformin in Patients with Type-2 Diabetes Mellitus. Research Journal of Pharmacy and Technology, 2019. 12(2): p. 531-534.
8. Subasree, S., Prevalence of Thyroid Disroders in India: An Overview. Research Journal of Pharmacy and Technology, 2014. 7(10): p. 1165.
9. Feely, J. and T.E. Isles, Screening for thyroid dysfunction in diabetics. Br Med J, 1979. 1(6179): p. 1678.
10. Thokada, S.S., H. Kandregula, and V. Mugada, Prevalence of Sub-Clinical Hypothyroidism among Diabetes Mellitus Patients with Vascular Complications. Asian Journal of Research in Pharmaceutical Science, 2018. 8(4): p. 253-257.
11. Kale, M., K. Bhusari, and S. Umathe, Relationship between the Dynamics of Oxidative Stress and Thyroid State. Research Journal of Pharmacy and Technology, 2008. 1(1): p. 14-17.
12. Perros, P., et al., Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med, 1995. 12(7): p. 622-7.
13. Ladenson, P.W., et al., American Thyroid Association guidelines for detection of thyroid dysfunction. Archives of Internal Medicine, 2000. 160(11): p. 1573-1575.
14. Gordon, D. and E. Ridgway, Thyroid-stimulating hormone: physiology and secretion. Endocrinology adult and pediatric. 6th edn. Philadelphia: Saunders, 2010: p. 1376-8.
15. Scheen, A.J., Drug interactions of clinical importance with antihyperglycaemic agents. Drug Safety, 2005. 28(7): p. 601-631.
16. Vigersky, R.A., A. Filmore-Nassar, and A.R. Glass, Thyrotropin suppression by metformin. The Journal of Clinical Endocrinology and Metabolism, 2006. 91(1): p. 225-227.
17. Cappelli, C., et al., TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care, 2009. 32(9): p. 1589-1590.
18. Díez, J.J. and P. Iglesias, Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clinical Endocrinology, 2013. 78(4): p. 505-511.
19. Hu, X., et al., Metformin affects thyroid function in male rats. Oncotarget, 2017. 8(64): p. 107589.
20. Santos-Palacios, S., et al., Does metformin have a “buffer effect” on serum TSH levels in euthyroid diabetic patients? Hormones, 2015. 14(2): p. 280-285.
21. Karimifar, M., et al., Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: a randomized placebo-controlled clinical trial. Journal of research in medical sciences: the official Journal of Isfahan University of Medical Sciences, 2014. 19(11): p. 1019.
22. Krysiak, R., W. Szkrobka, and B. Okopien, Sex-dependent effect of metformin on hypothalamic-pituitary-thyroid axis activity in patients with subclinical hypothyroidism. Pharmacol Rep, 2016. 68(6): p. 1115-1119.
23. Menon, A. and M. Thenmozhi, Correlation between thyroid function and obesity. Research Journal of Pharmacy and Technology, 2016. 9(10): p. 1568.
24. Lupoli, R., et al., Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. The Journal of Clinical Endocrinology and Metabolism, 2014. 99(1): p. E143-E148.
25. Duntas, L.H., J. Orgiazzi, and G. Brabant, The interface between thyroid and diabetes mellitus. Clinical Endocrinology, 2011. 75(1): p. 1-9.
26. Łabuzek, K., et al., Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacological Reports, 2010. 62(5): p. 956-965.
27. Dimic, D., et al., The effect of metformin on TSH levels in euthyroid and hypothyroid newly diagnosed diabetes mellitus type 2 patients. Clinical Study, 2016. 433: p. 435.
28. Krysiak, R. and B. Okopien, The effect of metformin on the hypothalamic–pituitary–thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism. The Journal of Clinical Pharmacology, 2015. 55(1): p. 45-49.
29. Robert, A., A. Vigersky, and N. Filmore, Thyrotropin suppression by metformin. J Clin Endocrinol Metab, 2006. 91(1): p. 225-227.
30. Bogachus, L.D. and L.P. Turcotte, Genetic downregulation of AMPK-α isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. American Journal of Physiology-Cell Physiology, 2010. 299(6): p. C1549-C1561.
31. Alevizaki, M., Metformin and the thyroid: some questions still remain. Clinical Endocrinology, 2013. 78(4): p. 503-504.
32. Krysiak, R., W. Szkrobka, and B. Okopien, The effect of metformin on hypothalamic-pituitary-thyroid axis activity in women with interferon-induced hypothyroidism: A pilot study. Experimental and Clinical Endocrinology and Diabetes, 2016. 124(02): p. 71-76.
33. Krysiak, R., et al., The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. Pharmacological Reports, 2016. 68(2): p. 490-494.